Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)

02 15METHYLPHENIDATE HYDROCHLORIDE

03 4TIMOLOL (TIMOLOL MALEATE)

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : TRUSOPT

2024 ACI Convention
Not Confirmed
arrow

Brand Name : TRUSOPT

arrow
2024 ACI Convention
Not Confirmed

Elvium Life Science

Dosage Form : SOLUTION

Dosage Strength : 2%

Packaging : 5ML

Brand Name : TRUSOPT

Approval Date :

Application Number : 2216205

Regulatory Info : Prescription

Registration Country : Canada

blank

02

Brand Name : COSOPT

2024 ACI Convention
Not Confirmed
arrow

Brand Name : COSOPT

arrow
2024 ACI Convention
Not Confirmed

Elvium Life Science

Dosage Form : SOLUTION

Dosage Strength : 20MG/ML

Packaging : 10ML

Brand Name : COSOPT

Approval Date :

Application Number : 2240113

Regulatory Info : Prescription

Registration Country : Canada

blank

03

Brand Name : COSOPT PRESERVATIVE-...

2024 ACI Convention
Not Confirmed
arrow

Brand Name : COSOPT PRESERVATIVE-...

arrow
2024 ACI Convention
Not Confirmed

Elvium Life Science

Dosage Form : SOLUTION

Dosage Strength : 20MG/ML

Packaging : 60X0.2ML

Brand Name : COSOPT PRESERVATIVE-FREE

Approval Date :

Application Number : 2258692

Regulatory Info : Prescription

Registration Country : Canada

blank

04

Brand Name : TRUSOPT PRESERVATIVE...

2024 ACI Convention
Not Confirmed
arrow

Brand Name : TRUSOPT PRESERVATIVE...

arrow
2024 ACI Convention
Not Confirmed

Elvium Life Science

Dosage Form : SOLUTION

Dosage Strength : 2%/W/V

Packaging : 0.2ML

Brand Name : TRUSOPT PRESERVATIVE-FREE

Approval Date :

Application Number : 2269090

Regulatory Info : Prescription

Registration Country : Canada

blank

05

Brand Name : FOQUEST

2024 ACI Convention
Not Confirmed
arrow

Brand Name : FOQUEST

arrow
2024 ACI Convention
Not Confirmed

Elvium Life Science

Dosage Form : CAPSULE (CONTROLLED RELEASE)

Dosage Strength : 35MG

Packaging : 60

Brand Name : FOQUEST

Approval Date :

Application Number : 2470306

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

06

Brand Name : FOQUEST

2024 ACI Convention
Not Confirmed
arrow

Brand Name : FOQUEST

arrow
2024 ACI Convention
Not Confirmed

Elvium Life Science

Dosage Form : CAPSULE (CONTROLLED RELEASE)

Dosage Strength : 45MG

Packaging : 60

Brand Name : FOQUEST

Approval Date :

Application Number : 2470314

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

07

Brand Name : FOQUEST

2024 ACI Convention
Not Confirmed
arrow

Brand Name : FOQUEST

arrow
2024 ACI Convention
Not Confirmed

Elvium Life Science

Dosage Form : CAPSULE (CONTROLLED RELEASE)

Dosage Strength : 55MG

Packaging : 60

Brand Name : FOQUEST

Approval Date :

Application Number : 2470322

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

08

Brand Name : FOQUEST

2024 ACI Convention
Not Confirmed
arrow

Brand Name : FOQUEST

arrow
2024 ACI Convention
Not Confirmed

Elvium Life Science

Dosage Form : CAPSULE (CONTROLLED RELEASE)

Dosage Strength : 70MG

Packaging : 60

Brand Name : FOQUEST

Approval Date :

Application Number : 2470330

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

09

Brand Name : FOQUEST

2024 ACI Convention
Not Confirmed
arrow

Brand Name : FOQUEST

arrow
2024 ACI Convention
Not Confirmed

Elvium Life Science

Dosage Form : CAPSULE (CONTROLLED RELEASE)

Dosage Strength : 85MG

Packaging : 60

Brand Name : FOQUEST

Approval Date :

Application Number : 2470349

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

10

Brand Name : FOQUEST

2024 ACI Convention
Not Confirmed
arrow

Brand Name : FOQUEST

arrow
2024 ACI Convention
Not Confirmed

Elvium Life Science

Dosage Form : CAPSULE (CONTROLLED RELEASE)

Dosage Strength : 100MG

Packaging : 60

Brand Name : FOQUEST

Approval Date :

Application Number : 2470357

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank